ITI Pharma and Healthcare Fund Regular - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Very High
-
₹17.29
(-0.2%)
Current NAV 06-12-2024
-
45.79%
Returns
-
Min. SIP ₹500
Min. Investment ₹5000
Asset Allocation (As on 31-Oct-2024)
Allocation of Equity and Debt Asset Classes.
- Equity 98.2%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
Category | Allocation |
---|---|
Large Cap | 38.11 |
Small Cap | 33.66 |
Mid Cap | 26.43 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Pharmaceuticals & Biotechnology
Healthcare Services
Insurance
Fertilizers & Agrochemicals
Chemicals & Petrochemicals
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
Stocks | Market Cap | Sectors (PE Ratio) 06-Dec-2024 |
Holdings | PE Ratio 06-Dec-2024 |
1Y Return |
---|---|---|---|---|---|
Sun Pharmaceutical Industries Limited | Large Cap | Pharmaceuticals & Biotechnology (49.19) | 15.6% | 39.18 | 45.55% |
Lupin Limited | Mid Cap | Pharmaceuticals & Biotechnology (132.95) | 6.72% | 167.31 | 197.56% |
Suven Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 6.06% | 136.52 | 95.6% |
Apollo Hospitals Enterprise Limited | Large Cap | Healthcare Services (98.06) | 5.42% | 87.81 | 30.35% |
Divis Laboratories Limited | Large Cap | Pharmaceuticals & Biotechnology (49.19) | 4.76% | 88.89 | 64.55% |
Aurobindo Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (49.19) | 3.94% | 20.26 | 22.94% |
Dr. Reddys Laboratories Limited | Large Cap | Pharmaceuticals & Biotechnology | 3.38% | - | 0% |
Zydus Lifesciences Limited | Large Cap | Pharmaceuticals & Biotechnology (49.19) | 3.11% | 22.55 | 56.59% |
IPCA Laboratories Limited | Mid Cap | Pharmaceuticals & Biotechnology (49.19) | 3.05% | 59 | 36.52% |
Laurus Labs Limited | Small Cap | Pharmaceuticals & Biotechnology (46.65) | 2.9% | 0 | 9.05% |
Syngene International Limited | Mid Cap | Healthcare Services (77.96) | 2.59% | 76.9 | 27.57% |
Piramal Pharma Limited | Small Cap | Pharmaceuticals & Biotechnology (22.59) | 2.38% | 0 | -26.02% |
Max Healthcare Institute Limited | Mid Cap | Healthcare Services (98.06) | 2.15% | 100.74 | 67.26% |
Aster DM Healthcare Limited | Small Cap | Healthcare Services (98.06) | 2.09% | 4.54 | 21.57% |
Orchid Pharma Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.97% | 74.85 | 212.46% |
Torrent Pharmaceuticals Limited | Large Cap | Pharmaceuticals & Biotechnology (49.19) | 1.95% | 62.51 | 60.05% |
Strides Pharma Science Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.91% | 28.41 | 46.27% |
Alkem Laboratories Limited | Mid Cap | Pharmaceuticals & Biotechnology (38.82) | 1.81% | 57.92 | -8.63% |
Healthcare Global Enterprises Limited | Small Cap | Healthcare Services (98.06) | 1.72% | 123.33 | 38.44% |
FDC Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.69% | 26.38 | 25.21% |
Shilpa Medicare Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.65% | 137.02 | 126.92% |
Mankind Pharma Limited | Large Cap | Pharmaceuticals & Biotechnology (49.19) | 1.54% | 48.97 | 32.4% |
Vijaya Diagnostic Centre Limited | Small Cap | Healthcare Services (98.06) | 1.44% | 88.35 | 87.52% |
Caplin Point Laboratories Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.44% | 36.22 | 95.08% |
Fortis Healthcare Limited | Mid Cap | Healthcare Services (98.06) | 1.35% | 82.36 | 85.53% |
Ajanta Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (49.19) | 1.34% | 40.9 | 47.31% |
Rainbow Childrens Medicare Limited | Small Cap | Healthcare Services (98.06) | 1.25% | 72.32 | 50.61% |
Gland Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (49.19) | 1.21% | 43.04 | 2.28% |
Supriya Lifescience Limited | Small Cap | Pharmaceuticals & Biotechnology (29.86) | 1.2% | 0 | 0% |
GlaxoSmithKline Pharmaceuticals Limited | Mid Cap | Pharmaceuticals & Biotechnology (49.19) | 1.2% | 58.88 | 39.18% |
HDFC Life Insurance Company Limited | Large Cap | Insurance (22.18) | 1.2% | 80.91 | -5.96% |
Cipla Limited | Large Cap | Pharmaceuticals & Biotechnology (49.19) | 1.15% | 26.67 | 22.57% |
Emcure Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology | 1.11% | - | 0% |
Biocon Limited | Mid Cap | Pharmaceuticals & Biotechnology (49.19) | 1.07% | 31.61 | 57.65% |
Neuland Laboratories Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.05% | 80.35 | 245.41% |
Alembic Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 1.05% | 32.96 | 41.82% |
Sumitomo Chemical India Limited | Small Cap | Fertilizers & Agrochemicals (56.84) | 1.03% | 57.02 | 33.69% |
Archean Chemical Industries Limited | Small Cap | Chemicals & Petrochemicals (51.16) | 0.96% | 38.95 | 17.65% |
Wockhardt Limited | Small Cap | Pharmaceuticals & Biotechnology (49.19) | 0.76% | -78.39 | 305.91% |
Discover More with Premium Access
View Stock InformationIf you Have any Specific Question Chat with our Expert Investment Advisor
Chat on WhatsAppFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for ITI Pharma and Healthcare Fund Regular ?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for ITI Pharma and Healthcare Fund Regular ?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.